Niopharma Labs Polskasp. z o.o. in liquidation
Manufacture of pharmaceutical preparations
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2014-05-23
Share capital
18,000.00 PLN
Registered address
Warszawa, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Trademarks
Niopharma Labs Polska currently holds no active trademarks with the Polish Patent Office. 8 marks have expired or were not registered. The first mark was filed in 2014.
| Mark | Protected until | |
|---|---|---|
| Hydrotropik(word) | – | |
| PROBIOŻELKI | – | |
| Elektrolitki(word) | – | |
| ELEKTROLITKI | – | |
| Probiożelki(word) | – |
Authorized Representatives
Agnieszka Krystyna Rafałowska – Liquidator
Iwona Teresa Czekałowska – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Iwona Teresa Czekałowskaage 63 | 21 | $283.63 | 5.8333% |
Ewa Pawlakage 56 | 21 | $283.63 | 5.8333% |
Agnieszka Krystyna Rafałowskaage 56 | 68 | $918.42 | 18.8889% |
Marek Emil Rafałowskiage 70 | 208 | $2,809.29 | 57.7778% |
Sławomir Mariusz Stolińskiage 56 | 31 | $418.69 | 8.6111% |
Others | 11 | $148.57 | 3.0556% |
Marek Emil Rafałowski and Agnieszka Krystyna Rafałowska hold a combined 76.7% – the ownership structure indicates family control.
Beneficial owners
No beneficial owners recorded for the company Niopharma Labs Polska.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jun 2, 2016 | Liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2016-06-06 | Name change (Niopharma Labs Polska → Niopharma Labs Polska Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2016-05-09 | Liquidation opened | |
| 2015-12-07 | Share capital increase (14,500.00 PLN → 18,000.00 PLN) | |
| 2015-11-17 | Share capital increase (10,000.00 PLN → 14,500.00 PLN) | |
| 2015-11-17 | PKD change (Removed: 39 codes) |
FAQ
The main business activity of Niopharma Labs Polska focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on May 23, 2014.
The headquarters is located at: Odrowąża 15, 03-310 Warszawa.
The share capital of the company is PLN 18,000 (approx. $4,862).
Last updated: 2026-07-04